Vaxess Technologies
Samir Gadhia began their career in 2018 as an Intern- Retail Pharmacy at Shiraz chemists and druggist. In 2021, they joined Dr. Jeffrey Agar's Lab as a Graduate Researcher. In 2022, they joined Vaxess Technologies as a Research and Development Co-op, where they supported early-stage product development activities, identified formulations that maintain shelf stability, and achieved ideal release of vaccine. Samir also strategically carried out screening of different excipients, performed assays, designed studies, executed experiments, analyzed data, troubleshot challenges, and communicated results.
Samir Gadhia has a High School Diploma from Lilavatibai Podar Sr Secondary School and a Bachelor of Pharmacy from Dr. Bhanuben Nanavati College of Pharmacy. Samir is currently pursuing a Master of Science in Pharmaceutical Sciences, specializing in Pharmaceutics and Drug Delivery at Northeastern University. Samir has also obtained certifications in Computer Aided Drug Design/Discovery, Pharmacovigilance, and Drug Regulatory Affairs from LearnToUpgrade and Dr. Bhanuben Nanavati College of Pharmacy.
Vaxess Technologies
Vaxess Technologies is a venture capital and Gates Foundation-backed life science company developing novel vaccine formulations and delivery technologies based on its proprietary silk platform. They are committed to improving access to vaccines by enabling better, more stable vaccine products that can be easily delivered all over the world.